Different Subtypes of α1-Adrenoceptor Modulate Different K+ Currents via Different Signaling Pathways in Canine Ventricular Myocytes

Huizhen Wang,Baofeng Yang,Yiqiang Zhang,Hong Han,Jingxiong Wang,Hong Shi,Zhiguo Wang

DOI: https://doi.org/10.1074/jbc.m105572200

IF: 5.485

2001-01-01

Journal of Biological Chemistry

Abstract:Abstract Multiple subtypes (α1A, α1B, and α1D) of α1-adrenoreceptors (α1ARs) co-exist in the heart and mediate a variety of cellular functions. We studied α1AR modulation of inward rectifier (I K1) and transient outward (I to) K+ currents in canine ventricular myocytes. Phenylephrine at 10 μm depressed only I to without affectingI K1 and at 100 μm inhibited bothI to and I K1. The effect of phenylephrine on I to was abolished by (+)niguldipine (10 nm) to inhibit α1AARs but not by chloroethyclonidine (10 μm) to inactivate α1BARs nor by BMY-7378 to antagonize α1DARs. In contrast, phenylephrine inhibition ofI K1 was reversed only by BMY-7378 (1 nm). PDD (100 nm, phorbol ester activator of protein kinase C (PKC)) simulates and bisindolylmaleimide (50 nm, PKC inhibitor) weakens phenylephrine modulation ofI to but not I K1. Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor KN-93 and inhibitor peptides abolished the effects of phenylephrine on I K1. Enhancement of PKC or CaMKII activities was seen in α1aAR- or α1dAR-transfected HEK293 cells and in myocytes pretreated with 10 or 100 μm phenylephrine, respectively. Our data suggest that different subtypes of α1ARs selectively modulate different cardiac K+ currents via different signal transduction mechanisms; α1AARs mediateI to regulation via PKC, and α1DARs mediate I K1 regulation via CaMKII.